Business
MustGrow Announces Record Q1-2025 Results: $3.8 Million Revenue, 14.3% Gross Profit Margin, $4.4 Million in Cash and Inventory
Investor Webcast: Wednesday, May 28th at 4:00pm ET / 1:00pm PT Register/View Here: https://u...
About this update from Mustgrow Biologics Corp.
[{"type":"text","content":"MustGrow Announces Record Q1-2025 Results: $3.8 Million Revenue, 14.3% Gross Profit Margin, $4.4 Million in Cash and InventoryInvestor Webcast: Wednesday, May 28th at 4:00pm ET / 1:00pm PTRegister/View Here: https://us02web.zoom.us/webinar/register/6217478678603/WN_h8uMVWINQsmS3HWF8K59WgPlease join/register at least 5 minutes prior to the call.Questions emailed to [email protected] will be addressed during the Q&A portion of the webcast.Saskatoon, Saskatchewan--(Newsfile Corp. - May 27, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the \"Company\" or \"MustGrow\"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended March 31, 2025. For complete details, please refer to the Q1-2025 Condensed Interim Financial Statements and associated Management's Discussion and Analysis, available on SEDAR+: www.sedarplus.ca or on the Company's website: www.mustgrow.ca.Key Financial Highlights:Sales revenue of $3.8 million was recorded in Q1-2025 vs. zero in Q1-2024Gross profit of $541,221 (14.3% gross profit margin) in Q1-2025(1)Cash and equivalents on hand as at March 31, 2025 was $2.0 million with Inventory of $2.4 millionNet loss for the three-month period ended March 31, 2025 was $1.6 million and the net loss per share was $0.03 (basic) for the same period\"Our 2025 first quarter marked a pivotal milestone for MustGrow, reflecting the first full quarter of revenue since the acquisition of the NexusBioAg sales and distribution business on December 31, 2024,\" stated Corey Giasson, President and CEO of MustGrow. \"$3.8 million is a meaningful revenue figure for us, and with additional products already secured for the NexusBioAg distribution platform and increasing commercial farmer interest in our TerraSanteTM U.S. biofertility product, we are accelerating our mission to improve the global food system through sustainable production solutions.\"The Company continues to focus on capital allocation that generates revenue and revenue growth of both its NexusBioAg Canadian sales and distribution business and TerraSanteTM biofertility sales in the United States.In the first quarter, MustGrow secured access to several additional agriculture products through its NexusBioAg sales and distribution platform in Canada, ...